Clinical Trial Update: Intravenous Mepolizumab In Children With Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 trial update on intravenous mepolizumab for pediatric eosinophilic esophagitis. The trial status is completed and results were posted in March 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Nucala (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Oesophagitis, Eosinophilic | Phase 2 | Status: COMPLETED | Results posted: 2016-03-10